IP Library › Granted Patent US 10,919,037
Granted Patent B2
US 10,919,037 · App. 16/087,500 · Granted Feb 16, 2021

Systems and apparatus for detecting compounds in human biological samples

Inventors: Wesley Philip Wong (Cambridge, MA); Clinton H. Hansen (Cambridge, MA); Mounir Ahmad Koussa (Somerville, MA)
Assignee: Children's Medical Center Corporation
B01L3/502715G01N27/44704G01N27/44743G01N33/48707G01N33/561B01L2200/027B01L2200/10B01L2300/023B01L2300/027B01L2300/069B01L2400/0421G01N27/44756
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,919,037
App. No.
16/087,500
Granted
Feb 16, 2021
Kind
B2
Abstract

Systems and apparatus for performing analysis of human biological samples are described. Collected biological samples are combined with a substance including nucleic acid complexes and the combined substance is processed using gel electrophoresis. An indication of a detected compound in the biological sample and/or a particular medical condition associated with the detected compound is output from the apparatus.

Claims (28)

1. A diagnostic device configured to perform analysis of a human biological sample, the diagnostic device comprising:

an input interface configured to receive the human biological sample from a user, wherein the input interface comprises a wicking material configured to provide the received human biological sample to sample processing machinery;

the sample processing machinery configured to perform a gel electrophoresis process on a mixture including the received human biological sample combined with a plurality of nucleic acid nanoswitch molecules, wherein the plurality of nucleic acid nanoswitch molecules are configured to bind to at least one compound in the human biological sample, when present; and

an output interface configured to output a gel electrophoresis result based on the gel electrophoresis process performed by the sample processing machinery.

2. The diagnostic device of claim 1 , wherein the sample processing machinery comprises a chamber that includes the plurality of nucleic acid nanoswitch molecules wherein the mixture is formed in the chamber when the human biological sample is introduced into the chamber.

3. The diagnostic device of claim 2 , wherein the chamber includes a fluid comprising the plurality of nucleic acid nanoswitch molecules.

4. The diagnostic device of claim 2 , wherein the chamber is coated with a substance that includes the plurality of nucleic acid nanoswitch molecules.

5. The diagnostic device of claim 1 , wherein the input interface is configured to connect to a container to receive the human biological sample and/or the mixture.

6. The diagnostic device of claim 1 , wherein the input interface comprises a sample collection chamber.

7. The diagnostic device of claim 1 , wherein the sample processing machinery further comprises a gel substrate and power source configured to provide an electric field across the gel substrate to perform the gel electrophoresis process.

8. The diagnostic device of claim 1 , wherein the output interface comprises a transparent window that enables viewing of the gel electrophoresis result through the window.

9. The diagnostic device of claim 1 , wherein the output interface comprises a data communications interface configured to output data corresponding to the gel electrophoresis result to a computing device.

10. The diagnostic device of claim 9 , wherein the computing device comprises a cellular phone, a smartphone, or a tablet computer.

11. The diagnostic device of claim 9 , wherein the computing device comprises at least one network-connected computer, and wherein the output interface is configured to output the data corresponding to the gel electrophoresis result to the at least one network-connected computer via one or more networks.

12. The diagnostic device of claim 1 , wherein the output interface comprises an indicator provided on the device, wherein the indicator is configured to indicate the gel electrophoresis result to the user.

13. The diagnostic device of claim 1 , further comprising imaging components integrated within the diagnostic device, wherein the imaging components are configured to capture an image of the gel electrophoresis result.

14. The diagnostic device of claim 13 , wherein the imaging components include at least one radiation source and at least one radiation detector.

15. The diagnostic device of claim 14 , wherein the imaging components further include at least one filter arranged to filter photons detected by the at least one radiation detector.

16. The diagnostic device of claim 13 , wherein the output interface is configured to output the image captured by the imaging components.

17. The diagnostic device of claim 13 , further comprising at least one controller programmed to control the imaging components to capture the image of the gel electrophoresis result.

18. A diagnostic system, comprising:

a sample collection device configured to receive a human biological sample, wherein the sample collection device comprises a wicking material;

a sample processing device configured to perform a gel electrophoresis process on the human biological sample received by the sample processing device via the wicking material of the sample collection device; and

an imaging device configured to capture an image of a gel electrophoresis result produced by the gel electrophoresis process.

19. A high-throughput sample analyzer, comprising:

an input interface configured to receive a plurality of human biological samples, wherein the input interface comprises wicking material configured to provide the plurality of received human biological samples to sample processing machinery;

the sample processing machinery configured to perform a gel electrophoresis process for each of the received plurality of human biological samples, wherein the sample processing machinery includes a plurality of gel electrophoresis tracks, each of which is configured to interface with a mixture including one of the received human biological samples combined with a plurality of nucleic acid nanoswitch molecules, wherein the plurality of nucleic acid nanoswitch molecules are configured to bind to at least one compound in the human biological sample, when present; and

an output interface configured to output a gel electrophoresis result for each of the plurality of gel electrophoresis tracks based on the gel electrophoresis process performed by the sample processing machinery.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2025
From: KOUSSA, MOUNIR A.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 072203/0480 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2019
From: WONG, WESLEY PHILIP; HANSEN, CLINTON H.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 049860/0644 →
Continuity (2)
Provisional Application 62311977 · Mar 23, 2016
Related Publication 20190070604A1 · Mar 7, 2019
Cited By (3)
US 12,331,349 US 12,571,802 US 12,692,491